ARCHIVES

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

This article is from The Cancer Letter archive.

Vol. 26 No. 25 | June 23, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Newell Denies He’s Leaving For Job On West Coast, Says He Is A “Free Agent”

November 4, 1977

Columbia To Host U.S.- China Conference

February 15, 1980

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001